AngelMD is proud to announce that its Institutional Capital Placement Team (ICP) team has responded to the global surge in healthcare deal flow demand by building a syndicate of institutional investors that turn to AngelMD for curated deal flow. The team is now advising over $200M in transactional volume in the market with expectation of adding another $200M over the course of the Fall.
Clients of the ICP team must be raising a minimum of $5MM in a Series A round or later. ICP clients increasingly look to AngelMD for unique offerings in therapeutics, medical device and digital health categories.
“The demand on both the investment side of the equation and the startup side of the equation is at historic levels. We take pride in connecting discerning investors with curated opportunities that have significant investment potential while also making a positive contribution to the healthcare landscape.” said Bob Velez, Head of ICP
The Institutional Capital Placement team is a compliment to the AngelMD fund team that manages and launches venture capital funds as a sophisticated means for members and institutional partners to participate in healthcare investment opportunities.
AngelMD — an online Healthcare Investment Marketplace — connects and engages a network of healthcare providers and subject matter experts, angel and institutional investors and private healthcare companies to create better outcomes for investors, entrepreneurs and patients. If your startup is raising $5M or more, and is at a Series A or later, you may be eligible for representation by the ICP team. For more information, and to get your startup listed on AngelMD, visit https://www.angelmd.co